AstraZeneca acquired Fusion Pharmaceuticals for approximately US$2 billion in 2024.
1 report, 1 independent
Updated Aug 17
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
AstraZeneca acquired Fusion Pharmaceuticals for approximately US$2 billion in 2024.
Who's involved
What this event is mainly aboutFusion PharmaceuticalsAstraZeneca
Keep exploring
The entities involved
-
AstraZeneca
British-Swedish pharmaceutical company
Related events
- Amgen acquired Horizon Therapeutics, a company whose portfolio included a drug discovered by AstraZeneca.
- Chinese pharmaceutical companies are investing heavily in novel technologies while AstraZeneca confirms its Cambridge headquarters and CEO.
- Alnylam Pharmaceuticals announced new partnerships with AstraZeneca for drug development and with Ionis Pharmaceuticals for clinical trials.
- Major pharmaceutical companies, including Pfizer, AstraZeneca, and Merck, announced several new partnerships and acquisitions in the oncology sector.